Jelena Janjic Libby, Ph.D. is a patent agent with McDonnell Boehnen Hulbert & Berghoff LLP. Dr. Libby provides technological advice in support of validity, infringement and patentability analyses in the areas of biotechnology and chemistry.
Prior to joining MBHB, Dr. Libby was a Graduate Research Assistant at the University of Chicago where she developed creative synthesis of a new anti-cancer drug, leaucascandrolide A, and eleven analogs. She used Saccharomyces cerevisiae genetics and proteomics methods to isolate biological target of leucascandrolide A. Dr. Libby also synthesized and characterized acrylic adhesives as a Technical Aide for 3M Adhesives Technology Center.
Dr. Libby has various publications, including Nature Chemical Biology and Journal of the American Chemical Society.
Published Articles
"Synthesis Enables Identification of the Cellular Target of Leucascandrolide A and Neopeltolide." Nature Chemical Biology, 2008, 4, 418 - 424
"Synthesis of Leucascandrolide A via a Spontaneous Macrolactolization." Journal of the American Chemical Society, 2002, 124, 13670-13671.
"Synthesis of Leucascandrolide A.", Pure and Applied Chemistry, 2005, 77, 1161-1169 (invited submission, IUPAC ICOS-15, Nagoya, Japan).